Related Experiment Video
Updated: Aug 4, 2026

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
Published on: June 11, 2011
The effect of HIV infection on paediatric bacterial meningitis in Blantyre, Malawi
E M Molyneux1, M Tembo, K Kayira
1Paediatric Department College of Medicine, Box 360, Blantyre, Malawi. emolyneux@malawi.net
Insights
HIV-positive children with bacterial meningitis face higher mortality and relapse rates. Prevention of primary and recurrent infections is crucial for this vulnerable group.
Area of Science:
- Pediatrics
- Infectious Diseases
- Immunology
Background:
- Bacterial meningitis remains a significant cause of childhood morbidity and mortality.
- Human Immunodeficiency Virus (HIV) infection can alter the presentation and outcomes of infectious diseases.
Purpose of the Study:
- To compare the clinical presentation, disease progression, and outcomes of acute bacterial meningitis in children with and without HIV infection.
Main Methods:
- A double-blind, randomized, placebo-controlled trial involving 598 children (aged 2 months to 13 years) with acute bacterial meningitis.
- 459 children were tested for HIV serostatus, with dexamethasone as adjuvant therapy evaluated.
Main Results:
- HIV-positive children (34% of cohort) showed similar presentation but higher rates of shock and infection focus.
- Streptococcus pneumoniae was more common in HIV-positive children (52% vs. 32%), with a 67% relapse rate in this group.
- Mortality was significantly higher in HIV-positive children (65% vs. 36%), though survivor numbers were similar; hearing loss was less common in HIV-positive survivors.
Conclusions:
- HIV-positive children with bacterial meningitis experience severe outcomes, including high mortality and recurrent infections.
- Urgent strategies are needed to prevent both initial and subsequent episodes of bacterial meningitis in HIV-infected children.
Aim:
To compare presentation, progress, and outcome of acute bacterial meningitis in HIV seropositive and seronegative children.
Methods:
A double blind randomised placebo controlled study of the use of dexamethasone as adjuvant therapy in acute bacterial meningitis, in children aged 2 months to 13 years, was carried out from July 1997 to March 2001. A total of 598 children were enrolled, of whom 459 were tested for HIV serostatus.
Results:
Of the 459 children, 34% were HIV seropositive. Their presentation was similar to HIV seronegative children but more were shocked on arrival at hospital (33/157 v 12/302), and more had a focus of infection (85/157 v 57/302). HIV positive children had a higher incidence of Streptococcus pneumoniae infections (52% v 32%). Sixty four cases relapsed; 67% were in HIV positive patients. The mortality in HIV positive children was 65% compared with 36% in HIV negative children. The number of survivors in each group was similar. Hearing loss was more common in HIV negative than HIV positive children (66.3% v 47.2%). Steroid therapy had no influence on meningitis in HIV positive children, but the mortality in HIV negative children was 61% in children given steroids, and 39% in those who did not receive steroids.
Conclusion:
HIV seropositive children who develop bacterial meningitis have a high mortality and are prone to recurrent disease. There is an urgent need to prevent both primary and recurrent infections.
More Related Videos
Related Concept Videos
Bacterial Meningitis
Viral Meningitis
Cryptococcal Meningitis
Malaria
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology

